277 related articles for article (PubMed ID: 25862150)
21. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
22. Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study.
Egeberg A; Khalid U; Gislason GH; Mallbris L; Skov L; Hansen PR
JAMA Dermatol; 2015 Nov; 151(11):1200-5. PubMed ID: 26222707
[TBL] [Abstract][Full Text] [Related]
23. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
24. Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria.
Agarwal R; Debella YT; Giduma HD; Light RP
Nephrol Dial Transplant; 2012 Jan; 27(1):310-7. PubMed ID: 21669884
[TBL] [Abstract][Full Text] [Related]
25. Increased risk for incident thyroid diseases in people with psoriatic disease: A cohort study.
Wang SH; Wang J; Lin YS; Tung TH; Chi CC
J Am Acad Dermatol; 2019 Apr; 80(4):1006-1012. PubMed ID: 30528501
[TBL] [Abstract][Full Text] [Related]
26. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
[TBL] [Abstract][Full Text] [Related]
27. Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease.
Sud M; Tangri N; Pintilie M; Levey AS; Naimark D
Circulation; 2014 Aug; 130(6):458-65. PubMed ID: 24899688
[TBL] [Abstract][Full Text] [Related]
28. Pneumococcal pneumonia infection is associated with end-stage renal disease in adult hospitalized patients.
Huang ST; Lin CL; Chang YJ; Sher YP; Wu MJ; Shu KH; Sung FC; Kao CH
Kidney Int; 2014 Nov; 86(5):1023-30. PubMed ID: 24694991
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.
Ahlehoff O; Skov L; Gislason G; Lindhardsen J; Kristensen SL; Iversen L; Lasthein S; Gniadecki R; Dam TN; Torp-Pedersen C; Hansen PR
J Intern Med; 2013 Feb; 273(2):197-204. PubMed ID: 22963528
[TBL] [Abstract][Full Text] [Related]
30. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
Onuigbo MA
Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563
[TBL] [Abstract][Full Text] [Related]
31. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease.
Peralta CA; Shlipak MG; Fan D; Ordoñez J; Lash JP; Chertow GM; Go AS
J Am Soc Nephrol; 2006 Oct; 17(10):2892-9. PubMed ID: 16959827
[TBL] [Abstract][Full Text] [Related]
32. Contrast Medium Exposure During Computed Tomography and Risk of Development of End-Stage Renal Disease in Patients With Chronic Kidney Disease: A Nationwide Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study.
Hsieh MS; Chiu CS; How CK; Chiang JH; Sheu ML; Chen WC; Lin HJ; Hsieh VC; Hu SY
Medicine (Baltimore); 2016 Apr; 95(16):e3388. PubMed ID: 27100424
[TBL] [Abstract][Full Text] [Related]
33. The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥ 50 years.
Van Pottelbergh G; Bartholomeeusen S; Buntinx F; Degryse J
Nephrol Dial Transplant; 2012 Jun; 27(6):2297-303. PubMed ID: 22102615
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of warfarin dose requirements in patients with chronic kidney disease and end-stage renal disease.
Sakaan SA; Hudson JQ; Oliphant CS; Tolley EA; Cummings C; Alabdan NA; Self TH
Pharmacotherapy; 2014 Jul; 34(7):695-702. PubMed ID: 24851819
[TBL] [Abstract][Full Text] [Related]
35. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
[TBL] [Abstract][Full Text] [Related]
36. Association of psoriasis with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis.
Jing X; Zhuyuan W; Aijun C; Jianxia X; Kun H; Ping W
Front Med (Lausanne); 2023; 10():1175477. PubMed ID: 37250627
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis.
Haroon M; Adeeb F; Devlin J; O Gradaigh D; Walker F
Int J Rheum Dis; 2011 Aug; 14(3):255-60. PubMed ID: 21816021
[TBL] [Abstract][Full Text] [Related]
38. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
[TBL] [Abstract][Full Text] [Related]
39. Psoriasis and risk of heart failure: a nationwide cohort study.
Khalid U; Ahlehoff O; Gislason GH; Kristensen SL; Skov L; Torp-Pedersen C; Hansen PR
Eur J Heart Fail; 2014 Jul; 16(7):743-8. PubMed ID: 24903077
[TBL] [Abstract][Full Text] [Related]
40. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
Meisinger C; Döring A; Löwel H;
Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
